Profile: Abaxis Inc (ABAX.O)
26 May 2017
Abaxis, Inc., incorporated on January 12, 1989, is a developer, manufacturer and marketer of portable blood analysis systems that are used in medical specialties in human or veterinary patient care to provide clinicians with blood constituent measurements. The Company markets and sells its products around the world through independent distributors and direct sales force. The Company's segments are the medical market and the veterinary market. The Company's subsidiary, Abaxis Europe GmbH, markets and distributes diagnostic systems for medical and veterinary uses in the European and Asia Pacific markets.
The Company serves the customer group in the medical market consisting of physicians' office practices across multiple specialties, urgent care, outpatient and walk-in clinics (free-standing or hospital-connected), health screening operations, home care providers (national, regional or local), nursing homes, ambulance companies, oncology treatment clinics, dialysis centers, pharmacies, hospital laboratories, military installations (ships, field hospitals and mobile care units), pharmaceutical clinical trials and cruise ship lines. The Company's medical market products include Piccolo chemistry analyzers and consumable products.
The Company develops, manufactures and sells the Piccolo Xpress chemistry analyzer for use in human patient care to provide clinicians with blood constituent measurements. The Piccolo Xpress chemistry analyzer provides on the spot routine multi-chemistry and electrolyte results using a small patient sample size in any treatment setting. The Piccolo Xpress chemistry analyzer performs multiple routine general chemistry tests on whole blood, serum or plasma samples.
The Company manufactures the Piccolo profiles used with the Piccolo chemistry analyzers. The Piccolo profiles are packaged as single-use medical reagents, configured to aid in disease diagnosis or monitor disease treatment. The Company offers over 10 multi-test reagent disc products in the medical market.
The Company serves the customer group in the veterinary market consisting of companion animal hospitals, animal clinics with mixed practices of small animals, birds and reptiles, equine and bovine practitioners, veterinary emergency clinics, veterinary referral hospitals, universities, government, pharmaceutical companies, biotechnology companies and private research laboratories. The Company's veterinary market product offerings include VetScan chemistry analyzers and veterinary reagent discs, VetScan hematology instruments and related reagent kits, VetScan VSpro specialty analyzers and related consumables, VetScan i-STAT analyzers and related consumables and VetScan rapid tests. The Company develops, manufactures and sells the VetScan VS2 chemistry analyzers in this market segment. The VetScan VS2 is a chemistry, electrolyte, immunoassay and blood gas analyzer that delivers results from a sample of whole blood, serum or plasma. The VetScan profiles are packaged as single-use plastic veterinary reagent discs. Each reagent disc contains a diluent and all the profiles necessary to perform a multi-chemistry blood analysis. The Company offers approximately 10 multi-test reagent disc products used in its VetScan chemistry analyzers in the veterinary market.
The Company markets and distributes VetScan hematology instruments and related consumables. The Company's VetScan HM5 is an automated five-part cell counter offering a 22-parameter blood count analysis, including direct eosinophil counts and eosinophil percentage, specifically designed for veterinary applications in veterinary clinics, research laboratories, pharmaceutical and biotech companies. The Company markets and distributes VetScan VSpro, an on-site specialty analyzer and related consumables. The VSpro specialty analyzer assists in the diagnosis and evaluation of suspected bleeding disorders, toxicity and poisoning, evaluation of disseminated intravascular coagulation, hepatic disease and in monitoring therapy and the progression of disease states.
The Company markets and distributes VetScan i-STAT analyzers and related consumables. The Company's VetScan i-STAT is a handheld analyzer used to deliver blood gas, electrolyte, chemistry and hematology results in minutes from 2 to 3 drops of whole blood. The VetScan i-STAT offers disposable, single-use cartridges, including tests for acid and base analysis, blood gases, chemistry, hematology, electrolytes and some specialty tests, including Lactate, activated clotting time (ACT) and Cardiac Troponin I. In the veterinary market, the Company's VetScan Rapid Test product line consists of individual rapid tests that aid in the detection of specific diseases. The Company's VetScan Rapid Tests in the veterinary market include VetScan Canine Anaplasma Rapid Test, VetScan Canine Ehrlichia Rapid Test, VetScan Feline FeLV/FIV Rapid Test, VetScan Canine Heartworm Rapid Test, VetScan Canine Lyme Rapid Test, VetScan Canine Parvovirus Rapid Test and VetScan Giardia Rapid Test.
The Company competes with Alere Switzerland GmbH, Alfa Wassermann S.P.A., Ortho-Clinical Diagnostics, Inc., F. Hoffmann-La Roche Ltd., Abbott Point of Care, Inc., Idexx Laboratories, Inc. and Heska Corporation.
3240 Whipple Rd
UNION CITY CA 94587-1217